Krishna Institute of Medical Sciences Ltd - 543308 - Shareholder Meeting / Postal Ballot-Outcome of AGM
The 20th Annual General Meeting of the Company was held on August 11, 2022, and the business mentioned in the Notice dated May 19, 2022, was transacted. In this regard, please find enclosed the proceedings as required under Regulation 30, Part A of Schedule - III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to the provisions of Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed copy of newspaper advertisement of the unaudited standalone and consolidated financial results of the company for the 01st quarter ended 30th June, 2022 published on 11th August, 2022 in Financial Express (English) and Navatelangana (Telugu). Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
the audio recording of the earnings call and earnings presentation made on August 09, 2022, on Unaudited Financial Results (Consolidated and Standalone) of the Company for the quarter ended June 30, 2022, is available on the Company's website at: at https://www.kimshospitals.com/investors/ Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
The audio recording of the earnings call and earnings presentation made on August 09, 2022, on Unaudited Financial Results (Consolidated and Standalone) of the Company for the quarter ended June 30, 2022, is available on the Company's website at: at https://www.kimshospitals.com/investors/ Q1FY23 Quarterly Result Announced for Krishna Institute of Medical Sciences Ltd.
Healthcare Facilities firm Krishna Institute of Medical Sciences announced Q1FY23 Result : Q1FY23 Consolidated: From 1st April’22, “Sunshine Hospitals” has become a subsidiary of “KIMS Hospitals”, post completion of the acquisition of a 51.07% stake. Sunshine acquisition has consolidated KIMS hospital’s position in the existing market (AP & Telangana). At the same time, the Sunshine acquisition has helped KIMS hospital get a national recognition for Orthopaedics practice. Consolidated Revenue from operation grew by 33% QoQ basis to Rs. 4,955 mn. Consolidated EBITDA (excluding other income and INDAS adjustments) grew by 9% on QoQ basis to Rs. 1,312 mn Consolidated EBITDA Margin (excluding other income and INDAS adjustments) stands at 26.5%. The slight decline in EBITDA margin is due to the consolidation of Sunshine hospitals, which is operating at 17.8% EBITDA margin and also increased cost for employees, doctor and Power & Fuel cost at existing KIMS hospitals. The group continues to have a very strong balance sheet along with healthy operating cash flow and has built a strong financial foundation for the next phase of growth. Group continues to be Net Cash positive (Rs. 1,961 mn), which will be deployed for ongoing/upcoming projects. Result PDF Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Investor Presentation
Please find enclosed herewith the Investor Presentation on Un-Audited Financial Results of the Company for the 01st Quarter ended 30th June, 2022. Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release on the Un-Audited Financial Results of the Company for the 01st Quarter ended 30th June, 2022 Krishna Institute of Medical Sciences Ltd - 543308 - Approval Of Un-Audited Financial Results For The 01St Quarter Ended 30Th June, 2022
Krishna Institute of Medical Sciences Limited submits Un-Audited Financial Results for the 01st Quarter ended 30th June, 2022 Krishna Institute of Medical Sciences Ltd - 543308 - Board Meeting Outcome for Outcome Of Board Meeting Held On 10Th August 2022 Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Krishna Institute of Medical Sciences Limited submits the Financials Results for the 01st Quarter ended 30th June, 2022. Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Dr. Bhaskara Rao Bollineni - Founder & Managing Director, Dr. Abhinay Bollineni - Executive Director and CEO, and Mr. Vikas Maheshwari - Chief Financial Officer, would participate in a conference call with analysts and investors, being hosted by IIFL Securities on Thursday 11th August 2022, at 9:30 am IST, to discuss the company's business strategy and outlook post the declaration of Q1FY23 financial results.